Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Natera, Inc. v. CareDx, Inc.
Case Number:
1:20-cv-00038
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 24, 2025
Natera's $96M DNA Test Verdict Scrapped, Patents Axed
A Delaware federal judge Monday threw out Natera's $96 million patent infringement verdict against CareDx after determining that the asserted claims in its patents related to DNA tests for organ transplant recipients are invalid.
-
January 03, 2025
Natera Loses New Trial Bid After Winning $96M Patent Verdict
A Delaware federal judge denied Natera's bid for a new trial in a case where a jury awarded the DNA test company $96 million in damages after finding rival CareDx stole from one of its patents but didn't infringe a second patent, saying Friday that sufficient evidence backed the verdict.
-
January 29, 2024
CareDx Hit With $96M Infringement Verdict Over DNA Test IP
A Delaware jury has moved to award Natera over $96 million in damages after finding that rival CareDx infringed one of its patents through the sale of its DNA tests for organ transplant recipients.
-
December 11, 2023
One Natera Patent Falls, But Others Survive
A Delaware federal judge gave CareDx a partial win Monday in patent litigation filed by Natera, finding that one of three patents-at-issue was invalid as covering patent-ineligible subject matter.